Literature DB >> 17221837

Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer.

Jin Gao1, Rachael L Collard, Loan Bui, Adrian C Herington, David L Nicol, Judith A Clements.   

Abstract

BACKGROUND: Prostate cancer (PCa) and bone cell interactions are critical in the metastatic phase. Kallikrein 4 (KLK4/hK4) is expressed in both PCa and mineralized tissues. We determined if KLK4/hK4 expression was associated with, and influenced by, the bone environment of metastatic PCa.
METHODS: Immunohistochemistry, in vitro co-culture, cell migration, and attachment assays.
RESULTS: hK4 was localized to tumor cells and osteoblasts in bone metastases. KLK4/hK4 increased in LNCaP and PC3 cells co-cultured with SaOs2 cells; SaOs2 KLK4/hK4 was unchanged. Co-culture did not affect cell proliferation but altered alkaline phosphatase activity/mRNA levels in SaOs2 cells. KLK4-transfected PC3 cells had increased migration towards SaOs2 conditioned medium and greater attachment to the bone-matrix proteins, collagens I and IV.
CONCLUSIONS: hK4 expression and interaction with both tumor cells and osteoblasts suggests a role for hK4 in PCa bone metastasis. Whether this observation is unique to bone metastasis or reflects a role for hK4 in PCa metastasis generally is yet to be established.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17221837     DOI: 10.1002/pros.20465

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  17 in total

Review 1.  Kallikreins - The melting pot of activity and function.

Authors:  Magdalena Kalinska; Ulf Meyer-Hoffert; Tomasz Kantyka; Jan Potempa
Journal:  Biochimie       Date:  2015-09-25       Impact factor: 4.079

Review 2.  Unleashing the therapeutic potential of human kallikrein-related serine proteases.

Authors:  Ioannis Prassas; Azza Eissa; Gennadiy Poda; Eleftherios P Diamandis
Journal:  Nat Rev Drug Discov       Date:  2015-02-20       Impact factor: 84.694

3.  Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study.

Authors:  Julia Ciampa; Meredith Yeager; Laufey Amundadottir; Kevin Jacobs; Peter Kraft; Charles Chung; Sholom Wacholder; Kai Yu; William Wheeler; Michael J Thun; W Ryan Divers; Susan Gapstur; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Edward Giovannucci; Walter C Willett; Geraldine Cancel-Tassin; Olivier Cussenot; Antoine Valeri; David Hunter; Robert Hoover; Gilles Thomas; Stephen Chanock; Nilanjan Chatterjee
Journal:  Cancer Res       Date:  2011-03-03       Impact factor: 12.701

4.  Clinical significance of kallikrein-related peptidase-4 in oral cancer.

Authors:  Petros Papagerakis; Giuseppe Pannone; L I Zheng; Maria Athanassiou-Papaefthymiou; Yashuo Yamakoshi; Howard Stan McGuff; Omar Shkeir; Konstantinos Ghirtis; Silvana Papagerakis
Journal:  Anticancer Res       Date:  2015-04       Impact factor: 2.480

5.  Expression of human kallikrein 1-related peptidase 4 (KLK4) and MET phosphorylation in prostate cancer tissue: immunohistochemical analysis.

Authors:  Shoichiro Mukai; Kenji Yorita; Koji Yamasaki; Takahiro Nagai; Toyoharu Kamibeppu; Satoru Sugie; Kazutaka Kida; Chie Onizuka; Hiromasa Tsukino; Toshio Kamimura; Toshiyuki Kamoto; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2015-04-11       Impact factor: 4.174

6.  A variant of the KLK4 gene is expressed as a cis sense-antisense chimeric transcript in prostate cancer cells.

Authors:  John Lai; Melanie L Lehman; Marcel E Dinger; Stephen C Hendy; Tim R Mercer; Inge Seim; Mitchell G Lawrence; John S Mattick; Judith A Clements; Colleen C Nelson
Journal:  RNA       Date:  2010-04-20       Impact factor: 4.942

7.  Hypomaturation enamel defects in Klk4 knockout/LacZ knockin mice.

Authors:  James P Simmer; Yuanyuan Hu; Rangsiyakorn Lertlam; Yasuo Yamakoshi; Jan C-C Hu
Journal:  J Biol Chem       Date:  2009-05-06       Impact factor: 5.157

Review 8.  Functional roles of human kallikrein-related peptidases.

Authors:  Georgia Sotiropoulou; Georgios Pampalakis; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2009-10-09       Impact factor: 5.157

Review 9.  Oncogenic activation of androgen receptor.

Authors:  Hsing-Jien Kung; Christopher P Evans
Journal:  Urol Oncol       Date:  2009 Jan-Feb       Impact factor: 3.498

10.  Genetic association of the KLK4 locus with risk of prostate cancer.

Authors:  Felicity Lose; Srilakshmi Srinivasan; Tracy O'Mara; Louise Marquart; Suzanne Chambers; Robert A Gardiner; Joanne F Aitken; Amanda B Spurdle; Jyotsna Batra; Judith A Clements
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.